{"disease":{"id":"postpartum-mood-disorder","name":"postpartum mood disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03803189","title":"Proactive, Personalized Postpartum Mental Healthcare","phase":"NA","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Women's College Hospital","has_results":false},{"nct_id":"NCT03228394","title":"A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Marinus Pharmaceuticals","has_results":true},{"nct_id":"NCT03460756","title":"A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"Marinus Pharmaceuticals","has_results":true},{"nct_id":"NCT05746507","title":"Night Respite for Postpartum Mothers With SUD","phase":"NA","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}